Implantable Cardiac Defibrillator-Related Culture-Negative Infection: A Case of Coxiella burnetii Infection.
Panteleimon E PapakonstantinouVictoria GeorgiadouGrigorios DoumanisVasiliki BistolaJoseph PapaparaskevasGerasimos S FilippatosSotirios XydonasPublished in: Journal of clinical medicine (2023)
Coxiella burnetii is one of the most common causes of blood culture-negative infective endocarditis (IE). However, only a few cases of cardiac implantable electronic devices (CIED) infection have been reported in the literature. Herein, we present a case of CIED-related blood culture-negative infection attributed to C. burnetii . A 54-year-old male was admitted to our hospital due to prolonged fatigue, a low-grade fever lasting more than a month, and weight loss. Three years ago, he received an implantable cardiac defibrillator (ICD) as a primary prevention measure against sudden cardiac death. An initial transthoracic and transesophageal echocardiography showed a dilated left ventricle with severely impaired systolic function, while the ventricular pacing wire was inside the right ventricle with a large echogenic mass (2.2 × 2.5 cm) adherent to it. Repeated blood cultures were negative. The patient underwent transvenous lead extraction. A transesophageal echocardiography after the extraction revealed multiple vegetations on the tricuspid valve with moderate to severe valve regurgitation. A surgical replacement of the tricuspid valve was determined after a multidisciplinary heart team approach. Serology tests showed increased IgG antibodies in phase I (1:16,394) and phase II (1:8192), and a definite diagnosis of CIED infection was made based on the serological tests.
Keyphrases
- left ventricular
- mitral valve
- aortic valve
- aortic stenosis
- low grade
- cardiac resynchronization therapy
- heart failure
- pulmonary hypertension
- phase ii
- computed tomography
- clinical trial
- weight loss
- pulmonary artery
- healthcare
- high grade
- type diabetes
- palliative care
- early onset
- open label
- randomized controlled trial
- body mass index
- physical activity
- atrial fibrillation
- phase iii
- weight gain
- blood pressure
- coronary artery disease
- electronic health record
- roux en y gastric bypass